Epidemiological Study of Levofloxacin-resistant <i>Streptococcus pneumoniae </i>Isolated from 2003 Through 2006 in Japan-Reference-Cited by-同舟云学术

Epidemiological Study of Levofloxacin-resistant Streptococcus pneumoniae Isolated from 2003 Through 2006 in Japan

Published:2009 Issue:2 Volume:83 Page:113-119
ISSN:0387-5911
Container-title:Kansenshogaku Zasshi
language:en
Short-container-title:J. J. A. Inf. D

Author:

YOKOZAWA Ikuyo¹,SOHMA Maemi¹,SATAKE Sachiko²,KANEKO Shingaku¹

Affiliation:

1. Division of Clinical Microbiology, Department of Clinical Laboratory, Maebashi Red Cross Hospital

2. School of Health Sciences, Gunma University

Publisher

The Japanese Association for Infectious Diseases

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/kansenshogakuzasshi/83/2/83_113/_pdf

Reference7 articles.

1. 4 Felder KA, Biedenbach DJ, Jones RN： Assesment of pathogen frequency and resistance patterns among pediatric patient isolates : report from the 2004 SENTRY antimicrobial surveil ance program on 3 continents. Diagn Microbiol Infect Dis 2006；56：427―36.

2. 5 Inoue M, Kaneko K, Akizawa K, Fujita S, Kaku M, Igari J, et al.： Antimicrobial susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1-3 (1999-2002). J Infect Chemother 2006；12：9―21.

3. 6 Yamaguti K, Ohno A of the Levofloxacin Surveillance Group： Investigatin of the susceptibility trends in Japan to fluoroquinolones and other antimicrobial agents in a nationwide collection of clinical isolates : a longitudinal analysis from 1994 to 2002. Diagn Microbiol Infect Dis 2005；52：135―43.

4. 7 Brant AO, Ronald NJ, Jan V, Ad F, Mondell LB,and The SENTRY antimicrobial surveillance group (Americas and Europe)：Antimicrobial activity of gatifloxacin (AM-1155, CG5501), and four other fluoroquinolones tested against 2,284 recent clinical strains of Streptococcus pnemoniae from Europe, Latin America, Canada, and the United States. Diagn Microbiol Infect Dis 1999；34：315―20.

5. 10 Clinical and Laboratory Standards Institute： Performance standards for Antimicrobial Susceptibility Testing ; Sixteenth Informational Supplement M100-S16. CLSI, Wayne, 2006；p. 134― 6.